Find and replace: editing human genome in pluripotent stem cells
β Scribed by Huize Pan; Weiqi Zhang; Weizhou Zhang; Guang-Hui Liu
- Book ID
- 107692180
- Publisher
- SP Higher Education Press
- Year
- 2011
- Tongue
- English
- Weight
- 123 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1674-800X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Induced pluripotent stem cell (iPSC) technology has emerged as the most promising method for generating patientβspecific human embryonic stem (ES) cells and adult stem cells (Takahashi et al., 2007, Cell 131:861β872; Wernig et al., 2007, Nature 448:318β324; Park et al., 2008, Nature 451
Orthotropic liver transplantation is the only established treatment for end-stage liver diseases. Utilization of hepatocyte transplantation and bio-artificial liver devices as alternative therapeutic approaches requires an unlimited source of hepatocytes. Stem cells, especially embryonic stem cells,
With the advent of induced pluripotent stem cell (iPSC) technology, it is now feasible to generate iPSCs with a defined genotype or disease state. When coupled with direct differentiation to a defined lineage, such as hepatic endoderm (HE), iPSCs would revolutionize the way we study human liver biol
## Abstract Induced pluripotent stem (iPS) cells derived from terminally differentiated human fibroblasts are reprogrammed to possess stem cell like properties. However, the extent to which iPS cells exhibit unique properties of the human embryonic stem (hES) cell cycle remains to be established. h